www.allsides.com
Abortion pill ruling could be &;quot;catastrophic&;quot; for new drug development
The Supreme Court today will hear a challenge to the FDA's approval of mifepristone‚ a medicine used to help induce abortions.
Why it matters: Were SCOTUS to rule in favor of mifepristone's opponents‚ it could chill future biotech investment for almost every medical indication.
Zoom out: The core question in the case is over whether the FDA has sole discretion to determine a drug's efficacy and safety‚ or if courts also can play a role.
The former is how biotech has traditionally...